Renal effects of beta-adrenoceptor blockade (Q72450399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Renal effects of beta-adrenoceptor blockade (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

M A Weber

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J I Drayer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

language of work or name

English

0 references

publication date

1 November 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

686-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

Inhibitory effect of propranolol on the vasoconstrictor response to sympathetic nerve stimulation

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effects on lipomobilisation of the beta-adrenergic blocking drugs, propranolol and INPEA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Treatment of cardiac arrhythmias in unanesthetized patients. Role of adrenergic beta receptor blockade.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Comparative chronotropic activity of beta-adrenoceptive antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Differentiation of receptors responsive to isoproterenol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Appraisal of the effects of catecholamines on cardiac electrical activity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Elimination of nadolol by patients with renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Pharmacokinetics of practolol in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Propranolol therapy in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Blood pressure and renin during treatment with pindolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Low-dose diuretic and beta adrenoceptor blocker in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Glomerular Filtration Rate and Renal Plasma Flow in Patients with Essential Hypertension before and after Treatment with Alprenolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The long-term effect of propranolol therapy on renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Mechanism of Increased Sodium Reabsorption during Propranolol Administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Propranolol in hypertension: a study of long-term therapy, 1964-1970

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Haemodynamic studies in hypertensive patients treated by oral propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Hemodynamic effects of practolol at rest and during exercise.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The assessment of β-adrenoceptor blocking drugs in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

A novel response to propranolol: contractile response in the isolated rabbit ear artery

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Exaggerated natriuresis in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Mechanism of exaggerated natriuresis in hypertensive man: impaired sodium transport in the loop of Henle

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effects of Chronic Beta-Adrenergic Blockade on Systemic and Renal Haemodynamic Responses to Hyperosmotic Saline in Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Intrarenal pressure and exaggerated natriuresis in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of an intravenous sodium chloride load on renal hemodynamics and electrolyte excretion in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of sodium loading and exercise on renal haemodynamics and urinary sodium excretion in young patients with essential hypertension before and during propranolol treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Plasma Volume and Extracellular Fluid Volume during Long-Term Treatment with Propranolol in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Plasma volume changes with long-term beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Albumin transcapillary escape rate and plasma volume during long-term beta-adrenergic blockade in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

A proposed cybernetic system for sodium and potassium homeostasis: coordination of aldosterone and intrarenal physical factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of Renal Beta- and Alpha-Adrenergic Stimulation on Proximal Sodium Reabsorption in Dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The Effects of Clonidine and Propranolol, Separately and in Combination, on Blood Pressure and Plasma Renin Activity in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Kalemotropic effect of epinephrine: analysis with adrenergic agonists and antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

HEPATIC METABOLIC AND VASCULAR RESPONSES TO EPINEPHRINE: A UNIFYING HYPOTHESIS

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1980.186

1 reference

7 January 2021

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Physiology of the juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

CONTROL OF RENIN SECRETION IN THE ANESTHETIZED DOG

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Beta-adrenoreceptor blockade in the conscious rabbit: Effects on plasma renin activity and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of hemorrhage with and without fluid replacement on plasma renin activity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Renin release by rat kidney slices in vitro: effects of cations and catecholamines

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of theophylline and adrenergic blocking drugs on the renin response to norepinephrine in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Evidence for an intrarenal beta receptor in control of renin release

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Adenyl cyclase as an adrenergic receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effects of Sodium Depletion on Plasma Renin Activity and on the Urinary Excretion of Cyclic AMP and Aldosterone in Hypoparathyroid Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Beta-blockers and plasma renin activity in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Propranolol in the Treatment of Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Propranolol Effects in Long-Term Hemodialysis Patients with Renin-Dependent Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

The effect of exogenous angiotensin on superficial and deep glomeruli in the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effect of hemorrhage and vasopressor agents on distribution of renal blood flow

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Renal cortical blood flow and glomerular filtration in myohemoglobinuric acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Renin and acute renal failure: studies in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Renin, renin substrate, and angiotensin I-converting enzyme in the lymph of rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Reduction in severity of acute renal failure in rats by beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Effects of renal artery occlusion on kidney function in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Angiotensin interaction with thirst mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Central action of angiotensin in stimulating ADH release

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Disparate patterns of aldosterone response during diuretic treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Relationships of Renin and Aldosterone to Antihypertensive Effects of Spironolactone and Propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.186

7 January 2021

Identifiers

DOI

10.1038/KI.1980.186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6109787%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference